nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—SLCO2A1—Phenobarbital—epilepsy syndrome	0.436	1	CbGbCtD
Alprostadil—Lubiprostone—CLCN2—epilepsy syndrome	0.00782	0.894	CrCbGaD
Alprostadil—PTGIR—hindbrain—epilepsy syndrome	0.00356	0.0698	CbGeAlD
Alprostadil—SLCO2B1—ganglion—epilepsy syndrome	0.00294	0.0576	CbGeAlD
Alprostadil—PTGIR—brainstem—epilepsy syndrome	0.00204	0.04	CbGeAlD
Alprostadil—PTGIR—forebrain—epilepsy syndrome	0.00197	0.0386	CbGeAlD
Alprostadil—PTGER1—head—epilepsy syndrome	0.00183	0.0358	CbGeAlD
Alprostadil—PTGIR—telencephalon—epilepsy syndrome	0.00181	0.0355	CbGeAlD
Alprostadil—PTGER1—nervous system—epilepsy syndrome	0.00173	0.0339	CbGeAlD
Alprostadil—PTGER1—central nervous system—epilepsy syndrome	0.00167	0.0327	CbGeAlD
Alprostadil—ABCC5—telencephalon—epilepsy syndrome	0.00145	0.0284	CbGeAlD
Alprostadil—PTGIR—spinal cord—epilepsy syndrome	0.00127	0.0249	CbGeAlD
Alprostadil—SLCO3A1—medulla oblongata—epilepsy syndrome	0.00126	0.0246	CbGeAlD
Alprostadil—SLCO2B1—forebrain—epilepsy syndrome	0.00123	0.0242	CbGeAlD
Alprostadil—SLCO3A1—midbrain—epilepsy syndrome	0.00115	0.0225	CbGeAlD
Alprostadil—ABCC5—medulla oblongata—epilepsy syndrome	0.00114	0.0223	CbGeAlD
Alprostadil—SLCO2B1—telencephalon—epilepsy syndrome	0.00113	0.0222	CbGeAlD
Alprostadil—PTGIR—head—epilepsy syndrome	0.00113	0.0221	CbGeAlD
Alprostadil—SLCO3A1—spinal cord—epilepsy syndrome	0.00112	0.022	CbGeAlD
Alprostadil—ABCC4—forebrain—epilepsy syndrome	0.00109	0.0214	CbGeAlD
Alprostadil—PTGIR—nervous system—epilepsy syndrome	0.00107	0.021	CbGeAlD
Alprostadil—ABCC5—midbrain—epilepsy syndrome	0.00104	0.0204	CbGeAlD
Alprostadil—PTGIR—central nervous system—epilepsy syndrome	0.00103	0.0202	CbGeAlD
Alprostadil—PTGIR—cerebellum—epilepsy syndrome	0.00101	0.0197	CbGeAlD
Alprostadil—SLCO3A1—head—epilepsy syndrome	0.000996	0.0195	CbGeAlD
Alprostadil—SLCO2A1—head—epilepsy syndrome	0.000987	0.0193	CbGeAlD
Alprostadil—SLCO3A1—nervous system—epilepsy syndrome	0.000944	0.0185	CbGeAlD
Alprostadil—SLCO2A1—nervous system—epilepsy syndrome	0.000935	0.0183	CbGeAlD
Alprostadil—SLCO3A1—central nervous system—epilepsy syndrome	0.000909	0.0178	CbGeAlD
Alprostadil—SLCO2A1—central nervous system—epilepsy syndrome	0.0009	0.0176	CbGeAlD
Alprostadil—SLCO2B1—medulla oblongata—epilepsy syndrome	0.000891	0.0175	CbGeAlD
Alprostadil—SLCO3A1—cerebellum—epilepsy syndrome	0.000889	0.0174	CbGeAlD
Alprostadil—PTGIR—brain—epilepsy syndrome	0.000818	0.016	CbGeAlD
Alprostadil—ABCC5—cerebellum—epilepsy syndrome	0.000805	0.0158	CbGeAlD
Alprostadil—SLCO2B1—spinal cord—epilepsy syndrome	0.000795	0.0156	CbGeAlD
Alprostadil—SLCO3A1—brain—epilepsy syndrome	0.000722	0.0141	CbGeAlD
Alprostadil—SLCO2A1—brain—epilepsy syndrome	0.000715	0.014	CbGeAlD
Alprostadil—SLCO2B1—head—epilepsy syndrome	0.000706	0.0138	CbGeAlD
Alprostadil—SLCO2B1—nervous system—epilepsy syndrome	0.00067	0.0131	CbGeAlD
Alprostadil—ABCC5—brain—epilepsy syndrome	0.000654	0.0128	CbGeAlD
Alprostadil—SLCO2B1—central nervous system—epilepsy syndrome	0.000645	0.0126	CbGeAlD
Alprostadil—SLCO2B1—cerebellum—epilepsy syndrome	0.00063	0.0123	CbGeAlD
Alprostadil—ABCC4—head—epilepsy syndrome	0.000625	0.0123	CbGeAlD
Alprostadil—ABCC4—nervous system—epilepsy syndrome	0.000593	0.0116	CbGeAlD
Alprostadil—ABCC4—central nervous system—epilepsy syndrome	0.000571	0.0112	CbGeAlD
Alprostadil—SLCO2B1—brain—epilepsy syndrome	0.000512	0.01	CbGeAlD
Alprostadil—ABCC4—brain—epilepsy syndrome	0.000453	0.00888	CbGeAlD
Alprostadil—Dinoprostone—SLCO1A2—epilepsy syndrome	0.000381	0.0436	CrCbGaD
Alprostadil—Dinoprostone—CYP11A1—epilepsy syndrome	0.000332	0.0379	CrCbGaD
Alprostadil—Dihomo-gamma-linolenic acid—PTGS2—epilepsy syndrome	0.000213	0.0244	CrCbGaD
Alprostadil—Body temperature increased—Zonisamide—epilepsy syndrome	0.000108	0.000353	CcSEcCtD
Alprostadil—Asthenia—Fosphenytoin—epilepsy syndrome	0.000108	0.000352	CcSEcCtD
Alprostadil—Visual impairment—Gabapentin—epilepsy syndrome	0.000108	0.000352	CcSEcCtD
Alprostadil—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000108	0.000352	CcSEcCtD
Alprostadil—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000108	0.00035	CcSEcCtD
Alprostadil—Pain—Carbamazepine—epilepsy syndrome	0.000107	0.000349	CcSEcCtD
Alprostadil—Dizziness—Propofol—epilepsy syndrome	0.000107	0.000348	CcSEcCtD
Alprostadil—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000107	0.000348	CcSEcCtD
Alprostadil—Pruritus—Fosphenytoin—epilepsy syndrome	0.000107	0.000347	CcSEcCtD
Alprostadil—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000107	0.000347	CcSEcCtD
Alprostadil—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000107	0.000346	CcSEcCtD
Alprostadil—Asthenia—Vigabatrin—epilepsy syndrome	0.000106	0.000343	CcSEcCtD
Alprostadil—Dizziness—Midazolam—epilepsy syndrome	0.000105	0.000341	CcSEcCtD
Alprostadil—Body temperature increased—Clonazepam—epilepsy syndrome	0.000105	0.00034	CcSEcCtD
Alprostadil—Abdominal pain—Clonazepam—epilepsy syndrome	0.000105	0.00034	CcSEcCtD
Alprostadil—Pruritus—Vigabatrin—epilepsy syndrome	0.000104	0.000338	CcSEcCtD
Alprostadil—Asthenia—Diazepam—epilepsy syndrome	0.000104	0.000338	CcSEcCtD
Alprostadil—Body temperature increased—Phenytoin—epilepsy syndrome	0.000104	0.000338	CcSEcCtD
Alprostadil—Pain—Lamotrigine—epilepsy syndrome	0.000104	0.000337	CcSEcCtD
Alprostadil—Nervousness—Pregabalin—epilepsy syndrome	0.000104	0.000337	CcSEcCtD
Alprostadil—Renal failure—Topiramate—epilepsy syndrome	0.000104	0.000337	CcSEcCtD
Alprostadil—Nausea—Acetazolamide—epilepsy syndrome	0.000104	0.000337	CcSEcCtD
Alprostadil—Dizziness—Levetiracetam—epilepsy syndrome	0.000103	0.000336	CcSEcCtD
Alprostadil—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000103	0.000336	CcSEcCtD
Alprostadil—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000103	0.000336	CcSEcCtD
Alprostadil—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000103	0.000336	CcSEcCtD
Alprostadil—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000103	0.000336	CcSEcCtD
Alprostadil—Back pain—Pregabalin—epilepsy syndrome	0.000103	0.000336	CcSEcCtD
Alprostadil—Cough—Valproic Acid—epilepsy syndrome	0.000103	0.000335	CcSEcCtD
Alprostadil—Muscle spasms—Pregabalin—epilepsy syndrome	0.000103	0.000333	CcSEcCtD
Alprostadil—Pruritus—Diazepam—epilepsy syndrome	0.000102	0.000333	CcSEcCtD
Alprostadil—Urinary tract infection—Topiramate—epilepsy syndrome	0.000102	0.000333	CcSEcCtD
Alprostadil—Rash—Propofol—epilepsy syndrome	0.000102	0.000332	CcSEcCtD
Alprostadil—Dermatitis—Propofol—epilepsy syndrome	0.000102	0.000332	CcSEcCtD
Alprostadil—Hypertension—Valproic Acid—epilepsy syndrome	0.000102	0.000331	CcSEcCtD
Alprostadil—Headache—Propofol—epilepsy syndrome	0.000101	0.00033	CcSEcCtD
Alprostadil—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000101	0.000327	CcSEcCtD
Alprostadil—Asthenia—Felbamate—epilepsy syndrome	0.000101	0.000327	CcSEcCtD
Alprostadil—Haematuria—Topiramate—epilepsy syndrome	0.0001	0.000326	CcSEcCtD
Alprostadil—Feeling abnormal—Lamotrigine—epilepsy syndrome	9.99e-05	0.000325	CcSEcCtD
Alprostadil—Rash—Midazolam—epilepsy syndrome	9.99e-05	0.000325	CcSEcCtD
Alprostadil—Dizziness—Fosphenytoin—epilepsy syndrome	9.98e-05	0.000325	CcSEcCtD
Alprostadil—Dermatitis—Midazolam—epilepsy syndrome	9.98e-05	0.000324	CcSEcCtD
Alprostadil—Discomfort—Valproic Acid—epilepsy syndrome	9.93e-05	0.000323	CcSEcCtD
Alprostadil—Headache—Midazolam—epilepsy syndrome	9.92e-05	0.000323	CcSEcCtD
Alprostadil—Pruritus—Felbamate—epilepsy syndrome	9.92e-05	0.000322	CcSEcCtD
Alprostadil—Abdominal pain—Carbamazepine—epilepsy syndrome	9.91e-05	0.000322	CcSEcCtD
Alprostadil—Body temperature increased—Carbamazepine—epilepsy syndrome	9.91e-05	0.000322	CcSEcCtD
Alprostadil—Diarrhoea—Diazepam—epilepsy syndrome	9.91e-05	0.000322	CcSEcCtD
Alprostadil—Sinusitis—Topiramate—epilepsy syndrome	9.88e-05	0.000321	CcSEcCtD
Alprostadil—Rash—Levetiracetam—epilepsy syndrome	9.86e-05	0.000321	CcSEcCtD
Alprostadil—Anaemia—Pregabalin—epilepsy syndrome	9.86e-05	0.000321	CcSEcCtD
Alprostadil—Dermatitis—Levetiracetam—epilepsy syndrome	9.85e-05	0.00032	CcSEcCtD
Alprostadil—Asthenia—Zonisamide—epilepsy syndrome	9.85e-05	0.00032	CcSEcCtD
Alprostadil—Dry mouth—Valproic Acid—epilepsy syndrome	9.82e-05	0.000319	CcSEcCtD
Alprostadil—Headache—Levetiracetam—epilepsy syndrome	9.8e-05	0.000319	CcSEcCtD
Alprostadil—Erythema—Gabapentin—epilepsy syndrome	9.78e-05	0.000318	CcSEcCtD
Alprostadil—Dizziness—Vigabatrin—epilepsy syndrome	9.73e-05	0.000316	CcSEcCtD
Alprostadil—Pruritus—Zonisamide—epilepsy syndrome	9.71e-05	0.000316	CcSEcCtD
Alprostadil—Oedema—Valproic Acid—epilepsy syndrome	9.63e-05	0.000313	CcSEcCtD
Alprostadil—Bradycardia—Topiramate—epilepsy syndrome	9.62e-05	0.000313	CcSEcCtD
Alprostadil—Nausea—Propofol—epilepsy syndrome	9.62e-05	0.000313	CcSEcCtD
Alprostadil—Diarrhoea—Felbamate—epilepsy syndrome	9.59e-05	0.000312	CcSEcCtD
Alprostadil—Body temperature increased—Lamotrigine—epilepsy syndrome	9.58e-05	0.000311	CcSEcCtD
Alprostadil—Abdominal pain—Lamotrigine—epilepsy syndrome	9.58e-05	0.000311	CcSEcCtD
Alprostadil—Dizziness—Diazepam—epilepsy syndrome	9.58e-05	0.000311	CcSEcCtD
Alprostadil—Infection—Valproic Acid—epilepsy syndrome	9.57e-05	0.000311	CcSEcCtD
Alprostadil—Syncope—Pregabalin—epilepsy syndrome	9.57e-05	0.000311	CcSEcCtD
Alprostadil—Rash—Fosphenytoin—epilepsy syndrome	9.52e-05	0.000309	CcSEcCtD
Alprostadil—Dermatitis—Fosphenytoin—epilepsy syndrome	9.51e-05	0.000309	CcSEcCtD
Alprostadil—Haemoglobin—Topiramate—epilepsy syndrome	9.5e-05	0.000309	CcSEcCtD
Alprostadil—Nervousness—Gabapentin—epilepsy syndrome	9.5e-05	0.000309	CcSEcCtD
Alprostadil—Asthenia—Clonazepam—epilepsy syndrome	9.49e-05	0.000309	CcSEcCtD
Alprostadil—Rhinitis—Topiramate—epilepsy syndrome	9.48e-05	0.000308	CcSEcCtD
Alprostadil—Back pain—Gabapentin—epilepsy syndrome	9.46e-05	0.000308	CcSEcCtD
Alprostadil—Headache—Fosphenytoin—epilepsy syndrome	9.46e-05	0.000307	CcSEcCtD
Alprostadil—Haemorrhage—Topiramate—epilepsy syndrome	9.45e-05	0.000307	CcSEcCtD
Alprostadil—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.43e-05	0.000307	CcSEcCtD
Alprostadil—Asthenia—Phenytoin—epilepsy syndrome	9.43e-05	0.000306	CcSEcCtD
Alprostadil—Nausea—Midazolam—epilepsy syndrome	9.41e-05	0.000306	CcSEcCtD
Alprostadil—Hypoaesthesia—Topiramate—epilepsy syndrome	9.41e-05	0.000306	CcSEcCtD
Alprostadil—Muscle spasms—Gabapentin—epilepsy syndrome	9.4e-05	0.000306	CcSEcCtD
Alprostadil—Tachycardia—Valproic Acid—epilepsy syndrome	9.4e-05	0.000306	CcSEcCtD
Alprostadil—Diarrhoea—Zonisamide—epilepsy syndrome	9.39e-05	0.000305	CcSEcCtD
Alprostadil—Pharyngitis—Topiramate—epilepsy syndrome	9.38e-05	0.000305	CcSEcCtD
Alprostadil—Loss of consciousness—Pregabalin—epilepsy syndrome	9.38e-05	0.000305	CcSEcCtD
Alprostadil—Asthenia—Oxcarbazepine—epilepsy syndrome	9.38e-05	0.000305	CcSEcCtD
Alprostadil—Pruritus—Clonazepam—epilepsy syndrome	9.36e-05	0.000304	CcSEcCtD
Alprostadil—Skin disorder—Valproic Acid—epilepsy syndrome	9.35e-05	0.000304	CcSEcCtD
Alprostadil—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.31e-05	0.000303	CcSEcCtD
Alprostadil—Cough—Pregabalin—epilepsy syndrome	9.31e-05	0.000303	CcSEcCtD
Alprostadil—Pruritus—Phenytoin—epilepsy syndrome	9.29e-05	0.000302	CcSEcCtD
Alprostadil—Nausea—Levetiracetam—epilepsy syndrome	9.29e-05	0.000302	CcSEcCtD
Alprostadil—Rash—Vigabatrin—epilepsy syndrome	9.28e-05	0.000302	CcSEcCtD
Alprostadil—Dizziness—Felbamate—epilepsy syndrome	9.27e-05	0.000301	CcSEcCtD
Alprostadil—Dermatitis—Vigabatrin—epilepsy syndrome	9.27e-05	0.000301	CcSEcCtD
Alprostadil—Urethral disorder—Topiramate—epilepsy syndrome	9.27e-05	0.000301	CcSEcCtD
Alprostadil—Pruritus—Oxcarbazepine—epilepsy syndrome	9.25e-05	0.000301	CcSEcCtD
Alprostadil—Convulsion—Pregabalin—epilepsy syndrome	9.24e-05	0.000301	CcSEcCtD
Alprostadil—Headache—Vigabatrin—epilepsy syndrome	9.22e-05	0.0003	CcSEcCtD
Alprostadil—Hypertension—Pregabalin—epilepsy syndrome	9.21e-05	0.000299	CcSEcCtD
Alprostadil—Rash—Diazepam—epilepsy syndrome	9.13e-05	0.000297	CcSEcCtD
Alprostadil—Dermatitis—Diazepam—epilepsy syndrome	9.12e-05	0.000297	CcSEcCtD
Alprostadil—Visual impairment—Topiramate—epilepsy syndrome	9.11e-05	0.000296	CcSEcCtD
Alprostadil—Dizziness—Zonisamide—epilepsy syndrome	9.07e-05	0.000295	CcSEcCtD
Alprostadil—Headache—Diazepam—epilepsy syndrome	9.07e-05	0.000295	CcSEcCtD
Alprostadil—Diarrhoea—Clonazepam—epilepsy syndrome	9.05e-05	0.000294	CcSEcCtD
Alprostadil—Anaemia—Gabapentin—epilepsy syndrome	9.04e-05	0.000294	CcSEcCtD
Alprostadil—Hypotension—Valproic Acid—epilepsy syndrome	9e-05	0.000293	CcSEcCtD
Alprostadil—Asthenia—Carbamazepine—epilepsy syndrome	9e-05	0.000293	CcSEcCtD
Alprostadil—Diarrhoea—Phenytoin—epilepsy syndrome	8.99e-05	0.000292	CcSEcCtD
Alprostadil—Discomfort—Pregabalin—epilepsy syndrome	8.97e-05	0.000292	CcSEcCtD
Alprostadil—Nausea—Fosphenytoin—epilepsy syndrome	8.97e-05	0.000292	CcSEcCtD
Alprostadil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.94e-05	0.000291	CcSEcCtD
Alprostadil—Dry mouth—Pregabalin—epilepsy syndrome	8.88e-05	0.000289	CcSEcCtD
Alprostadil—Pruritus—Carbamazepine—epilepsy syndrome	8.87e-05	0.000288	CcSEcCtD
Alprostadil—Rash—Felbamate—epilepsy syndrome	8.84e-05	0.000287	CcSEcCtD
Alprostadil—Dermatitis—Felbamate—epilepsy syndrome	8.83e-05	0.000287	CcSEcCtD
Alprostadil—Headache—Felbamate—epilepsy syndrome	8.78e-05	0.000286	CcSEcCtD
Alprostadil—Flushing—Topiramate—epilepsy syndrome	8.77e-05	0.000285	CcSEcCtD
Alprostadil—Syncope—Gabapentin—epilepsy syndrome	8.77e-05	0.000285	CcSEcCtD
Alprostadil—Dizziness—Clonazepam—epilepsy syndrome	8.75e-05	0.000284	CcSEcCtD
Alprostadil—Nausea—Vigabatrin—epilepsy syndrome	8.74e-05	0.000284	CcSEcCtD
Alprostadil—Oedema—Pregabalin—epilepsy syndrome	8.71e-05	0.000283	CcSEcCtD
Alprostadil—Asthenia—Lamotrigine—epilepsy syndrome	8.7e-05	0.000283	CcSEcCtD
Alprostadil—Dizziness—Phenytoin—epilepsy syndrome	8.69e-05	0.000282	CcSEcCtD
Alprostadil—Rash—Zonisamide—epilepsy syndrome	8.65e-05	0.000281	CcSEcCtD
Alprostadil—Infection—Pregabalin—epilepsy syndrome	8.65e-05	0.000281	CcSEcCtD
Alprostadil—Dermatitis—Zonisamide—epilepsy syndrome	8.64e-05	0.000281	CcSEcCtD
Alprostadil—Dizziness—Oxcarbazepine—epilepsy syndrome	8.64e-05	0.000281	CcSEcCtD
Alprostadil—Nausea—Diazepam—epilepsy syndrome	8.6e-05	0.00028	CcSEcCtD
Alprostadil—Loss of consciousness—Gabapentin—epilepsy syndrome	8.6e-05	0.00028	CcSEcCtD
Alprostadil—Headache—Zonisamide—epilepsy syndrome	8.6e-05	0.00028	CcSEcCtD
Alprostadil—Diarrhoea—Carbamazepine—epilepsy syndrome	8.58e-05	0.000279	CcSEcCtD
Alprostadil—Pruritus—Lamotrigine—epilepsy syndrome	8.57e-05	0.000279	CcSEcCtD
Alprostadil—Shock—Pregabalin—epilepsy syndrome	8.57e-05	0.000278	CcSEcCtD
Alprostadil—Cough—Gabapentin—epilepsy syndrome	8.54e-05	0.000278	CcSEcCtD
Alprostadil—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.52e-05	0.000277	CcSEcCtD
Alprostadil—Tachycardia—Pregabalin—epilepsy syndrome	8.5e-05	0.000276	CcSEcCtD
Alprostadil—Dyspepsia—Valproic Acid—epilepsy syndrome	8.48e-05	0.000276	CcSEcCtD
Alprostadil—Convulsion—Gabapentin—epilepsy syndrome	8.48e-05	0.000276	CcSEcCtD
Alprostadil—Skin disorder—Pregabalin—epilepsy syndrome	8.46e-05	0.000275	CcSEcCtD
Alprostadil—Hypertension—Gabapentin—epilepsy syndrome	8.45e-05	0.000275	CcSEcCtD
Alprostadil—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.42e-05	0.000274	CcSEcCtD
Alprostadil—Rash—Clonazepam—epilepsy syndrome	8.34e-05	0.000271	CcSEcCtD
Alprostadil—Dermatitis—Clonazepam—epilepsy syndrome	8.33e-05	0.000271	CcSEcCtD
Alprostadil—Nausea—Felbamate—epilepsy syndrome	8.33e-05	0.000271	CcSEcCtD
Alprostadil—Dizziness—Carbamazepine—epilepsy syndrome	8.29e-05	0.00027	CcSEcCtD
Alprostadil—Diarrhoea—Lamotrigine—epilepsy syndrome	8.29e-05	0.00027	CcSEcCtD
Alprostadil—Headache—Clonazepam—epilepsy syndrome	8.29e-05	0.000269	CcSEcCtD
Alprostadil—Rash—Phenytoin—epilepsy syndrome	8.28e-05	0.000269	CcSEcCtD
Alprostadil—Dermatitis—Phenytoin—epilepsy syndrome	8.28e-05	0.000269	CcSEcCtD
Alprostadil—Rash—Oxcarbazepine—epilepsy syndrome	8.24e-05	0.000268	CcSEcCtD
Alprostadil—Pain—Valproic Acid—epilepsy syndrome	8.24e-05	0.000268	CcSEcCtD
Alprostadil—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.23e-05	0.000268	CcSEcCtD
Alprostadil—Headache—Phenytoin—epilepsy syndrome	8.23e-05	0.000268	CcSEcCtD
Alprostadil—Erythema—Topiramate—epilepsy syndrome	8.23e-05	0.000268	CcSEcCtD
Alprostadil—Discomfort—Gabapentin—epilepsy syndrome	8.23e-05	0.000268	CcSEcCtD
Alprostadil—Headache—Oxcarbazepine—epilepsy syndrome	8.19e-05	0.000266	CcSEcCtD
Alprostadil—Nausea—Zonisamide—epilepsy syndrome	8.15e-05	0.000265	CcSEcCtD
Alprostadil—Dry mouth—Gabapentin—epilepsy syndrome	8.14e-05	0.000265	CcSEcCtD
Alprostadil—Hypotension—Pregabalin—epilepsy syndrome	8.14e-05	0.000265	CcSEcCtD
Alprostadil—Dizziness—Lamotrigine—epilepsy syndrome	8.01e-05	0.000261	CcSEcCtD
Alprostadil—Nervousness—Topiramate—epilepsy syndrome	7.99e-05	0.00026	CcSEcCtD
Alprostadil—Oedema—Gabapentin—epilepsy syndrome	7.98e-05	0.00026	CcSEcCtD
Alprostadil—Back pain—Topiramate—epilepsy syndrome	7.96e-05	0.000259	CcSEcCtD
Alprostadil—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.94e-05	0.000258	CcSEcCtD
Alprostadil—Infection—Gabapentin—epilepsy syndrome	7.93e-05	0.000258	CcSEcCtD
Alprostadil—Muscle spasms—Topiramate—epilepsy syndrome	7.91e-05	0.000257	CcSEcCtD
Alprostadil—Rash—Carbamazepine—epilepsy syndrome	7.91e-05	0.000257	CcSEcCtD
Alprostadil—Dermatitis—Carbamazepine—epilepsy syndrome	7.9e-05	0.000257	CcSEcCtD
Alprostadil—Nausea—Clonazepam—epilepsy syndrome	7.86e-05	0.000255	CcSEcCtD
Alprostadil—Headache—Carbamazepine—epilepsy syndrome	7.86e-05	0.000255	CcSEcCtD
Alprostadil—Shock—Gabapentin—epilepsy syndrome	7.85e-05	0.000255	CcSEcCtD
Alprostadil—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.82e-05	0.000254	CcSEcCtD
Alprostadil—Nausea—Phenytoin—epilepsy syndrome	7.8e-05	0.000254	CcSEcCtD
Alprostadil—Tachycardia—Gabapentin—epilepsy syndrome	7.79e-05	0.000253	CcSEcCtD
Alprostadil—Nausea—Oxcarbazepine—epilepsy syndrome	7.76e-05	0.000252	CcSEcCtD
Alprostadil—Skin disorder—Gabapentin—epilepsy syndrome	7.75e-05	0.000252	CcSEcCtD
Alprostadil—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.72e-05	0.000251	CcSEcCtD
Alprostadil—Rash—Lamotrigine—epilepsy syndrome	7.64e-05	0.000248	CcSEcCtD
Alprostadil—Dermatitis—Lamotrigine—epilepsy syndrome	7.63e-05	0.000248	CcSEcCtD
Alprostadil—Abdominal pain—Valproic Acid—epilepsy syndrome	7.61e-05	0.000248	CcSEcCtD
Alprostadil—Body temperature increased—Valproic Acid—epilepsy syndrome	7.61e-05	0.000248	CcSEcCtD
Alprostadil—Anaemia—Topiramate—epilepsy syndrome	7.61e-05	0.000247	CcSEcCtD
Alprostadil—Headache—Lamotrigine—epilepsy syndrome	7.59e-05	0.000247	CcSEcCtD
Alprostadil—Hypotension—Gabapentin—epilepsy syndrome	7.46e-05	0.000243	CcSEcCtD
Alprostadil—Nausea—Carbamazepine—epilepsy syndrome	7.45e-05	0.000242	CcSEcCtD
Alprostadil—Pain—Pregabalin—epilepsy syndrome	7.45e-05	0.000242	CcSEcCtD
Alprostadil—Syncope—Topiramate—epilepsy syndrome	7.38e-05	0.00024	CcSEcCtD
Alprostadil—Loss of consciousness—Topiramate—epilepsy syndrome	7.23e-05	0.000235	CcSEcCtD
Alprostadil—Nausea—Lamotrigine—epilepsy syndrome	7.2e-05	0.000234	CcSEcCtD
Alprostadil—Cough—Topiramate—epilepsy syndrome	7.18e-05	0.000233	CcSEcCtD
Alprostadil—Feeling abnormal—Pregabalin—epilepsy syndrome	7.17e-05	0.000233	CcSEcCtD
Alprostadil—Convulsion—Topiramate—epilepsy syndrome	7.13e-05	0.000232	CcSEcCtD
Alprostadil—Hypertension—Topiramate—epilepsy syndrome	7.11e-05	0.000231	CcSEcCtD
Alprostadil—Dyspepsia—Gabapentin—epilepsy syndrome	7.03e-05	0.000228	CcSEcCtD
Alprostadil—Discomfort—Topiramate—epilepsy syndrome	6.92e-05	0.000225	CcSEcCtD
Alprostadil—Asthenia—Valproic Acid—epilepsy syndrome	6.91e-05	0.000225	CcSEcCtD
Alprostadil—Body temperature increased—Pregabalin—epilepsy syndrome	6.88e-05	0.000224	CcSEcCtD
Alprostadil—Abdominal pain—Pregabalin—epilepsy syndrome	6.88e-05	0.000224	CcSEcCtD
Alprostadil—Dry mouth—Topiramate—epilepsy syndrome	6.85e-05	0.000223	CcSEcCtD
Alprostadil—Pain—Gabapentin—epilepsy syndrome	6.83e-05	0.000222	CcSEcCtD
Alprostadil—Pruritus—Valproic Acid—epilepsy syndrome	6.81e-05	0.000222	CcSEcCtD
Alprostadil—Oedema—Topiramate—epilepsy syndrome	6.72e-05	0.000218	CcSEcCtD
Alprostadil—Infection—Topiramate—epilepsy syndrome	6.67e-05	0.000217	CcSEcCtD
Alprostadil—Shock—Topiramate—epilepsy syndrome	6.61e-05	0.000215	CcSEcCtD
Alprostadil—Diarrhoea—Valproic Acid—epilepsy syndrome	6.59e-05	0.000214	CcSEcCtD
Alprostadil—Feeling abnormal—Gabapentin—epilepsy syndrome	6.58e-05	0.000214	CcSEcCtD
Alprostadil—Thrombocytopenia—Topiramate—epilepsy syndrome	6.58e-05	0.000214	CcSEcCtD
Alprostadil—Tachycardia—Topiramate—epilepsy syndrome	6.56e-05	0.000213	CcSEcCtD
Alprostadil—Skin disorder—Topiramate—epilepsy syndrome	6.52e-05	0.000212	CcSEcCtD
Alprostadil—Hyperhidrosis—Topiramate—epilepsy syndrome	6.49e-05	0.000211	CcSEcCtD
Alprostadil—Dizziness—Valproic Acid—epilepsy syndrome	6.37e-05	0.000207	CcSEcCtD
Alprostadil—Body temperature increased—Gabapentin—epilepsy syndrome	6.31e-05	0.000205	CcSEcCtD
Alprostadil—Abdominal pain—Gabapentin—epilepsy syndrome	6.31e-05	0.000205	CcSEcCtD
Alprostadil—Hypotension—Topiramate—epilepsy syndrome	6.28e-05	0.000204	CcSEcCtD
Alprostadil—Asthenia—Pregabalin—epilepsy syndrome	6.25e-05	0.000203	CcSEcCtD
Alprostadil—Pruritus—Pregabalin—epilepsy syndrome	6.16e-05	0.0002	CcSEcCtD
Alprostadil—Rash—Valproic Acid—epilepsy syndrome	6.07e-05	0.000197	CcSEcCtD
Alprostadil—Dermatitis—Valproic Acid—epilepsy syndrome	6.07e-05	0.000197	CcSEcCtD
Alprostadil—Headache—Valproic Acid—epilepsy syndrome	6.03e-05	0.000196	CcSEcCtD
Alprostadil—Diarrhoea—Pregabalin—epilepsy syndrome	5.96e-05	0.000194	CcSEcCtD
Alprostadil—Dyspepsia—Topiramate—epilepsy syndrome	5.91e-05	0.000192	CcSEcCtD
Alprostadil—Dizziness—Pregabalin—epilepsy syndrome	5.76e-05	0.000187	CcSEcCtD
Alprostadil—Pain—Topiramate—epilepsy syndrome	5.74e-05	0.000187	CcSEcCtD
Alprostadil—Asthenia—Gabapentin—epilepsy syndrome	5.73e-05	0.000186	CcSEcCtD
Alprostadil—Nausea—Valproic Acid—epilepsy syndrome	5.72e-05	0.000186	CcSEcCtD
Alprostadil—Pruritus—Gabapentin—epilepsy syndrome	5.65e-05	0.000184	CcSEcCtD
Alprostadil—Feeling abnormal—Topiramate—epilepsy syndrome	5.53e-05	0.00018	CcSEcCtD
Alprostadil—Rash—Pregabalin—epilepsy syndrome	5.49e-05	0.000178	CcSEcCtD
Alprostadil—Dermatitis—Pregabalin—epilepsy syndrome	5.48e-05	0.000178	CcSEcCtD
Alprostadil—Diarrhoea—Gabapentin—epilepsy syndrome	5.46e-05	0.000178	CcSEcCtD
Alprostadil—Headache—Pregabalin—epilepsy syndrome	5.45e-05	0.000177	CcSEcCtD
Alprostadil—Abdominal pain—Topiramate—epilepsy syndrome	5.31e-05	0.000173	CcSEcCtD
Alprostadil—Body temperature increased—Topiramate—epilepsy syndrome	5.31e-05	0.000173	CcSEcCtD
Alprostadil—Dizziness—Gabapentin—epilepsy syndrome	5.28e-05	0.000172	CcSEcCtD
Alprostadil—Nausea—Pregabalin—epilepsy syndrome	5.17e-05	0.000168	CcSEcCtD
Alprostadil—Rash—Gabapentin—epilepsy syndrome	5.03e-05	0.000164	CcSEcCtD
Alprostadil—Dermatitis—Gabapentin—epilepsy syndrome	5.03e-05	0.000164	CcSEcCtD
Alprostadil—Headache—Gabapentin—epilepsy syndrome	5e-05	0.000163	CcSEcCtD
Alprostadil—Asthenia—Topiramate—epilepsy syndrome	4.82e-05	0.000157	CcSEcCtD
Alprostadil—Pruritus—Topiramate—epilepsy syndrome	4.75e-05	0.000155	CcSEcCtD
Alprostadil—Nausea—Gabapentin—epilepsy syndrome	4.74e-05	0.000154	CcSEcCtD
Alprostadil—Diarrhoea—Topiramate—epilepsy syndrome	4.6e-05	0.000149	CcSEcCtD
Alprostadil—Dizziness—Topiramate—epilepsy syndrome	4.44e-05	0.000144	CcSEcCtD
Alprostadil—Rash—Topiramate—epilepsy syndrome	4.23e-05	0.000138	CcSEcCtD
Alprostadil—Dermatitis—Topiramate—epilepsy syndrome	4.23e-05	0.000138	CcSEcCtD
Alprostadil—Headache—Topiramate—epilepsy syndrome	4.21e-05	0.000137	CcSEcCtD
Alprostadil—Nausea—Topiramate—epilepsy syndrome	3.99e-05	0.00013	CcSEcCtD
Alprostadil—PTGER1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.8e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BDKRB1—epilepsy syndrome	2.8e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CHRM2—epilepsy syndrome	2.8e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CX3CL1—epilepsy syndrome	2.8e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.8e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—ALB—epilepsy syndrome	2.8e-05	0.000142	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR7—epilepsy syndrome	2.75e-05	0.00014	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CDC42—epilepsy syndrome	2.74e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CDC42—epilepsy syndrome	2.74e-05	0.000139	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—GABBR1—epilepsy syndrome	2.73e-05	0.000138	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—GABBR1—epilepsy syndrome	2.73e-05	0.000138	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HBEGF—epilepsy syndrome	2.67e-05	0.000136	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AVP—epilepsy syndrome	2.65e-05	0.000135	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AVP—epilepsy syndrome	2.65e-05	0.000135	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT3—epilepsy syndrome	2.62e-05	0.000133	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HRH3—epilepsy syndrome	2.61e-05	0.000133	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HRH3—epilepsy syndrome	2.61e-05	0.000133	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—POMC—epilepsy syndrome	2.61e-05	0.000132	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—OPRM1—epilepsy syndrome	2.57e-05	0.000131	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—OPRM1—epilepsy syndrome	2.57e-05	0.000131	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—ADAM10—epilepsy syndrome	2.56e-05	0.00013	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—CCL2—epilepsy syndrome	2.55e-05	0.00013	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—FYN—epilepsy syndrome	2.53e-05	0.000129	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ABCG2—epilepsy syndrome	2.5e-05	0.000127	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—CCR5—epilepsy syndrome	2.48e-05	0.000126	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.48e-05	0.000126	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2C19—epilepsy syndrome	2.43e-05	0.000124	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—YWHAZ—epilepsy syndrome	2.43e-05	0.000124	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR3—epilepsy syndrome	2.43e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR3—epilepsy syndrome	2.43e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.43e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.43e-05	0.000123	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—S100B—epilepsy syndrome	2.42e-05	0.000123	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP11A1—epilepsy syndrome	2.42e-05	0.000123	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.4e-05	0.000122	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SOCS3—epilepsy syndrome	2.4e-05	0.000122	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CDC42—epilepsy syndrome	2.39e-05	0.000122	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.38e-05	0.000121	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NPY—epilepsy syndrome	2.37e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NPY—epilepsy syndrome	2.37e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ATP2A2—epilepsy syndrome	2.37e-05	0.00012	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.37e-05	0.00012	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SLC2A1—epilepsy syndrome	2.36e-05	0.00012	CbGpPWpGaD
Alprostadil—ABCC5—Disease—JUNB—epilepsy syndrome	2.34e-05	0.000119	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS1—epilepsy syndrome	2.32e-05	0.000118	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AVP—epilepsy syndrome	2.32e-05	0.000118	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.31e-05	0.000117	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AGT—epilepsy syndrome	2.3e-05	0.000117	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AGT—epilepsy syndrome	2.3e-05	0.000117	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	2.29e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL3—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL2—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—OXT—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HSPB1—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CRH—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HSPB1—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL2—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL3—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CRH—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—OXT—epilepsy syndrome	2.28e-05	0.000116	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCR5—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCR5—epilepsy syndrome	2.25e-05	0.000114	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	2.23e-05	0.000113	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HBEGF—epilepsy syndrome	2.22e-05	0.000113	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—HTR2A—epilepsy syndrome	2.2e-05	0.000112	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.2e-05	0.000112	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HES1—epilepsy syndrome	2.19e-05	0.000111	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CYP2D6—epilepsy syndrome	2.18e-05	0.000111	CbGpPWpGaD
Alprostadil—SLCO2B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.18e-05	0.000111	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT3—epilepsy syndrome	2.18e-05	0.000111	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PLAU—epilepsy syndrome	2.16e-05	0.00011	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FYN—epilepsy syndrome	2.13e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.13e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.13e-05	0.000108	CbGpPWpGaD
Alprostadil—ABCC5—Disease—ADAM10—epilepsy syndrome	2.13e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PTK2B—epilepsy syndrome	2.12e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PTK2B—epilepsy syndrome	2.12e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—H2AFX—epilepsy syndrome	2.12e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TSC1—epilepsy syndrome	2.12e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TSC1—epilepsy syndrome	2.12e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MEF2C—epilepsy syndrome	2.12e-05	0.000108	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AGT—epilepsy syndrome	2.09e-05	0.000106	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AGT—epilepsy syndrome	2.09e-05	0.000106	CbGpPWpGaD
Alprostadil—ABCC5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.08e-05	0.000106	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ADRA2A—epilepsy syndrome	2.08e-05	0.000106	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—BCHE—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NTRK2—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR2—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SST—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SST—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR2—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NTRK2—epilepsy syndrome	2.07e-05	0.000105	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.05e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—DUSP6—epilepsy syndrome	2.05e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—DUSP6—epilepsy syndrome	2.05e-05	0.000104	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—NGF—epilepsy syndrome	2.03e-05	0.000103	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.02e-05	0.000103	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADRA2A—epilepsy syndrome	2.02e-05	0.000103	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PLAT—epilepsy syndrome	2.01e-05	0.000102	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PLAT—epilepsy syndrome	2.01e-05	0.000102	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—PRKCB—epilepsy syndrome	2.01e-05	0.000102	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CDC42—epilepsy syndrome	1.99e-05	0.000101	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—NOS2—epilepsy syndrome	1.98e-05	0.000101	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—SRC—epilepsy syndrome	1.98e-05	0.000101	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—SLC2A1—epilepsy syndrome	1.97e-05	0.0001	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCR5—epilepsy syndrome	1.97e-05	0.0001	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PLCB1—epilepsy syndrome	1.95e-05	9.92e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—TH—epilepsy syndrome	1.95e-05	9.89e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.94e-05	9.87e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—BDKRB2—epilepsy syndrome	1.94e-05	9.87e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CXCL12—epilepsy syndrome	1.94e-05	9.87e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CXCL12—epilepsy syndrome	1.94e-05	9.87e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—POMC—epilepsy syndrome	1.94e-05	9.85e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—POMC—epilepsy syndrome	1.94e-05	9.85e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—PRKCB—epilepsy syndrome	1.93e-05	9.82e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.93e-05	9.82e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—HTR2A—epilepsy syndrome	1.93e-05	9.8e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—VEGFA—epilepsy syndrome	1.93e-05	9.79e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—IL6ST—epilepsy syndrome	1.93e-05	9.78e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.93e-05	9.78e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JUNB—epilepsy syndrome	1.91e-05	9.68e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JUNB—epilepsy syndrome	1.91e-05	9.68e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CNR1—epilepsy syndrome	1.91e-05	9.68e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CNR1—epilepsy syndrome	1.91e-05	9.68e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PLCB1—epilepsy syndrome	1.9e-05	9.65e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PLCB1—epilepsy syndrome	1.9e-05	9.65e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR7—epilepsy syndrome	1.86e-05	9.45e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR7—epilepsy syndrome	1.86e-05	9.45e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—TSC2—epilepsy syndrome	1.83e-05	9.31e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AGT—epilepsy syndrome	1.83e-05	9.29e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—HES1—epilepsy syndrome	1.82e-05	9.23e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HBEGF—epilepsy syndrome	1.81e-05	9.17e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HBEGF—epilepsy syndrome	1.81e-05	9.17e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—APOE—epilepsy syndrome	1.79e-05	9.11e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT3—epilepsy syndrome	1.77e-05	9e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT3—epilepsy syndrome	1.77e-05	9e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FYN—epilepsy syndrome	1.77e-05	8.98e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—H2AFX—epilepsy syndrome	1.76e-05	8.95e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—POMC—epilepsy syndrome	1.76e-05	8.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—POMC—epilepsy syndrome	1.76e-05	8.95e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—KDR—epilepsy syndrome	1.76e-05	8.92e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—ADAM10—epilepsy syndrome	1.73e-05	8.79e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—ADAM10—epilepsy syndrome	1.73e-05	8.79e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—CCL2—epilepsy syndrome	1.72e-05	8.75e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—CCL2—epilepsy syndrome	1.72e-05	8.75e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—YWHAZ—epilepsy syndrome	1.7e-05	8.63e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—PRKCB—epilepsy syndrome	1.69e-05	8.59e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—IL6ST—epilepsy syndrome	1.68e-05	8.55e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—ALB—epilepsy syndrome	1.67e-05	8.47e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—S100B—epilepsy syndrome	1.64e-05	8.32e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—S100B—epilepsy syndrome	1.64e-05	8.32e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—CCR5—epilepsy syndrome	1.63e-05	8.3e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—HMOX1—epilepsy syndrome	1.62e-05	8.25e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SOCS3—epilepsy syndrome	1.62e-05	8.23e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SOCS3—epilepsy syndrome	1.62e-05	8.23e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CDC42—epilepsy syndrome	1.62e-05	8.21e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CDC42—epilepsy syndrome	1.62e-05	8.21e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—CAT—epilepsy syndrome	1.6e-05	8.14e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AVP—epilepsy syndrome	1.57e-05	7.95e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AVP—epilepsy syndrome	1.57e-05	7.95e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ABCB1—epilepsy syndrome	1.56e-05	7.92e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—POMC—epilepsy syndrome	1.54e-05	7.82e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—TSC2—epilepsy syndrome	1.52e-05	7.72e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CCL2—epilepsy syndrome	1.51e-05	7.65e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—APOE—epilepsy syndrome	1.49e-05	7.55e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HES1—epilepsy syndrome	1.48e-05	7.52e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HES1—epilepsy syndrome	1.48e-05	7.52e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—GPX1—epilepsy syndrome	1.45e-05	7.36e-05	CbGpPWpGaD
Alprostadil—ABCC4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.44e-05	7.33e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FYN—epilepsy syndrome	1.44e-05	7.31e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FYN—epilepsy syndrome	1.44e-05	7.31e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—H2AFX—epilepsy syndrome	1.43e-05	7.29e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—H2AFX—epilepsy syndrome	1.43e-05	7.29e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MEF2C—epilepsy syndrome	1.43e-05	7.27e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MEF2C—epilepsy syndrome	1.43e-05	7.27e-05	CbGpPWpGaD
Alprostadil—ABCC4—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.42e-05	7.23e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—IL6ST—epilepsy syndrome	1.4e-05	7.1e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—NOS2—epilepsy syndrome	1.39e-05	7.04e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.38e-05	7.03e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—YWHAZ—epilepsy syndrome	1.38e-05	7.03e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—NGF—epilepsy syndrome	1.37e-05	6.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—NGF—epilepsy syndrome	1.37e-05	6.95e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—FGF2—epilepsy syndrome	1.36e-05	6.92e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCR5—epilepsy syndrome	1.33e-05	6.76e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCR5—epilepsy syndrome	1.33e-05	6.76e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—HTR2A—epilepsy syndrome	1.3e-05	6.62e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—HTR2A—epilepsy syndrome	1.3e-05	6.62e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AGT—epilepsy syndrome	1.27e-05	6.46e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—RELA—epilepsy syndrome	1.26e-05	6.42e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—APOE—epilepsy syndrome	1.25e-05	6.33e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MTOR—epilepsy syndrome	1.24e-05	6.3e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—TSC2—epilepsy syndrome	1.24e-05	6.29e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—TSC2—epilepsy syndrome	1.24e-05	6.29e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AGT—epilepsy syndrome	1.24e-05	6.28e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AGT—epilepsy syndrome	1.24e-05	6.28e-05	CbGpPWpGaD
Alprostadil—PTGIR—Hemostasis—AKT1—epilepsy syndrome	1.23e-05	6.25e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—APOE—epilepsy syndrome	1.21e-05	6.15e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—APOE—epilepsy syndrome	1.21e-05	6.15e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—KDR—epilepsy syndrome	1.19e-05	6.03e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—KDR—epilepsy syndrome	1.19e-05	6.03e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—SRC—epilepsy syndrome	1.18e-05	5.99e-05	CbGpPWpGaD
Alprostadil—PTGER2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.15e-05	5.85e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	1.15e-05	5.84e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—PRKCB—epilepsy syndrome	1.14e-05	5.8e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—PRKCB—epilepsy syndrome	1.14e-05	5.8e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—CASP3—epilepsy syndrome	1.14e-05	5.79e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—IL6ST—epilepsy syndrome	1.14e-05	5.78e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—IL6ST—epilepsy syndrome	1.14e-05	5.78e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—FGF2—epilepsy syndrome	1.13e-05	5.74e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—JUN—epilepsy syndrome	1.11e-05	5.63e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—MMP9—epilepsy syndrome	1.08e-05	5.47e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—POMC—epilepsy syndrome	1.07e-05	5.43e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling by GPCR—AKT1—epilepsy syndrome	1.05e-05	5.31e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—POMC—epilepsy syndrome	1.04e-05	5.28e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—POMC—epilepsy syndrome	1.04e-05	5.28e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—MTOR—epilepsy syndrome	1.03e-05	5.22e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—PTGS2—epilepsy syndrome	1.02e-05	5.18e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CCL2—epilepsy syndrome	1.02e-05	5.17e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CCL2—epilepsy syndrome	1.02e-05	5.17e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—SRC—epilepsy syndrome	9.93e-06	5.05e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—ALB—epilepsy syndrome	9.75e-06	4.95e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—VEGFA—epilepsy syndrome	9.68e-06	4.92e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—FGF2—epilepsy syndrome	9.2e-06	4.67e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—FGF2—epilepsy syndrome	9.2e-06	4.67e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—RELA—epilepsy syndrome	8.54e-06	4.34e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—RELA—epilepsy syndrome	8.54e-06	4.34e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—PTGS2—epilepsy syndrome	8.53e-06	4.33e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MTOR—epilepsy syndrome	8.37e-06	4.25e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MTOR—epilepsy syndrome	8.37e-06	4.25e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—SRC—epilepsy syndrome	8.24e-06	4.19e-05	CbGpPWpGaD
Alprostadil—PTGER1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.77e-06	3.95e-05	CbGpPWpGaD
Alprostadil—PTGIR—GPCR downstream signaling—AKT1—epilepsy syndrome	7.77e-06	3.95e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—CASP3—epilepsy syndrome	7.7e-06	3.91e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—CASP3—epilepsy syndrome	7.7e-06	3.91e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—JUN—epilepsy syndrome	7.48e-06	3.8e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—JUN—epilepsy syndrome	7.48e-06	3.8e-05	CbGpPWpGaD
Alprostadil—ABCC4—Hemostasis—AKT1—epilepsy syndrome	7.33e-06	3.72e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—MMP9—epilepsy syndrome	7.28e-06	3.7e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—MMP9—epilepsy syndrome	7.28e-06	3.7e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling by GPCR—AKT1—epilepsy syndrome	7.06e-06	3.59e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling by GPCR—AKT1—epilepsy syndrome	7.06e-06	3.59e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—SRC—epilepsy syndrome	6.71e-06	3.41e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—SRC—epilepsy syndrome	6.71e-06	3.41e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—VEGFA—epilepsy syndrome	6.54e-06	3.32e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—VEGFA—epilepsy syndrome	6.54e-06	3.32e-05	CbGpPWpGaD
Alprostadil—PTGER2—Signaling Pathways—AKT1—epilepsy syndrome	6.17e-06	3.14e-05	CbGpPWpGaD
Alprostadil—ABCC5—Disease—AKT1—epilepsy syndrome	5.12e-06	2.6e-05	CbGpPWpGaD
Alprostadil—ABCC5—Metabolism—AKT1—epilepsy syndrome	4.29e-06	2.18e-05	CbGpPWpGaD
Alprostadil—PTGER1—Signaling Pathways—AKT1—epilepsy syndrome	4.17e-06	2.12e-05	CbGpPWpGaD
Alprostadil—PTGIR—Signaling Pathways—AKT1—epilepsy syndrome	4.17e-06	2.12e-05	CbGpPWpGaD
